UNC Hospitals and outpatient dialysis clinics
Chapel Hill, North Carolina, 27514, United States
NCT Number: NCT01530945
Patients with end-stage kidney disease (ESKD) must manage not only the demands of dialysis and comorbid conditions but also associated symptoms and acute life-threatening events that contribute to functional limitations and increased risk of mortality. Yet little is known about the trajectories of quality of life dimensions in patients with ESKD when they experience acute life-threatening episodes, to guide palliative care for this population. In this prospective, descriptive study, we will identify trajectories of symptoms, physical functioning, psychosocial needs, and emotional and spiritual well-being in 200 patients with ESKD who are at a high risk of experiencing acute life-threatening events and mortality within 12 months.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Chapel Hill, North Carolina, 27514, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 12 months
University of North Carolina, Chapel Hill
Other
Mapping Multidimensional Illness Trajectories of Patients With ESKD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02513303
Arteriovenous Fistula, Arteriovenous Malformations
Huntsville, Alabama, United States
View Trial DetailsNCT05425056
Arteriovenous Fistula, Arteriovenous Malformations
San Diego, California, United States
View Trial DetailsNCT05836220
Chronic Disease, Disease Attributes
Anaheim, California, United States
View Trial DetailsNCT06581393
Chronic Disease, Disease Attributes
Ontario, California, United States
View Trial Details